How to Maintain Pregnancy After Successful IVF in Thailand? A Complete Guide to Luteal Phase Support Medication and Monitoring

AI Summary

▎Consultation Scenario   A 39-year-old patient underwent a frozen embryo transfer (artificial cycle) at a fertility center in Thailand in 2024. On day 12 after transfer, the pregnancy test showed: β-hCG 682 mIU/mL, progesterone 13.2 ng/mL, estradiol 186 pg/mL. The Thai doctor prescribed progesterone injection 40mg/day + Duphaston 20mg/day + Crinone 90mg/day. After returning home, the patient was unsure how long to continue the medication, when to reduce the dose, what to monitor, and whether brown discharge was normal.

1. The Four Most Frequently Asked Questions by Patients

In outpatient clinics, patients returning after successful IVF in Thailand have questions highly concentrated on the following four areas:

• How long should I take the medication? Luteal phase support medications are generally used until 10–12 weeks of gestation, after which they are gradually tapered off based on placental function. The specific discontinuation time should be determined by the doctor based on blood values, ultrasound, and individual circumstances.
• Which indicators need to be monitored? Mainly β-hCG, progesterone (P), estradiol (E2), and ultrasound to observe the gestational sac, yolk sac, fetal pole, and fetal heartbeat.
• What should I do if I have bleeding or abdominal pain? A small amount of brown discharge or mild lower abdominal discomfort is not uncommon in early pregnancy, but it is necessary to rule out ectopic pregnancy, threatened miscarriage, or Ovarian Hyperstimulation Syndrome (OHSS). Any bright red bleeding or severe abdominal pain requires immediate medical attention.
• What should I pay attention to in diet and lifestyle? Eat a normal, balanced diet; avoid raw, cold, or undercooked food. Strict bed rest is not necessary; moderate activity helps blood circulation and prevents thrombosis. Avoid sexual intercourse until after 12 weeks of gestation.

2. Direct Answer: What is the Core of Pregnancy Maintenance?

The core of pregnancy maintenance after successful IVF in Thailand is luteal phase support. During the IVF cycle, egg retrieval removes granulosa cells, leading to luteal phase deficiency. Additionally, the use of GnRH agonists or antagonists suppresses the pituitary-ovarian axis, limiting endogenous luteinizing hormone (LH) secretion, so the corpus luteum cannot maintain adequate progesterone production. Therefore, exogenous progesterone supplementation is essential to sustain early pregnancy.

The goal of pregnancy maintenance is to keep the endometrium in a secretory phase, providing a stable environment for embryo implantation and development until the placenta (around 10–12 weeks of gestation) can autonomously produce sufficient progesterone and estrogen.

3. Practical Process: Post-Transfer Medication and Monitoring Timeline

3.1 Common Luteal Phase Support Protocols (Commonly Used in Thailand)

Thai doctors often use combined protocols (e.g., injection + oral + vaginal) to supplement progesterone through different routes and maintain stable blood concentrations. Patients with frozen embryo transfers in artificial cycles also need estrogen supplementation.

3.2 Standard Post-Transfer Monitoring Timeline

The above is a general reference timeline. The specific monitoring frequency and medication adjustments should be individualized based on the patient's age, obstetric history, embryo quality, and early blood value changes.

4. Key Indicator Interpretation: β-hCG, Progesterone, Estradiol

4.1 β-hCG

β-hCG is a core indicator for assessing early pregnancy viability. The β-hCG level 12–14 days after transfer can preliminarily determine embryo implantation status:

• β-hCG < 5 mIU/mL: Not pregnant.
• β-hCG 5–50 mIU/mL: Suspicious pregnancy; repeat test in 2–3 days to check doubling.
• β-hCG > 50 mIU/mL: Confirmed pregnancy. In early normal pregnancy, β-hCG approximately doubles every 48–72 hours.
• When β-hCG > 2000 mIU/mL: A gestational sac should be visible on transvaginal ultrasound.

Note: The absolute β-hCG level does not directly equate to the final live birth rate. The doubling trend and subsequent ultrasound results are more important.

4.2 Progesterone (P)

Progesterone is a key hormone for maintaining early pregnancy. It promotes endometrial secretion, reduces uterine smooth muscle excitability, and supports embryonic development. In IVF cycles, the target progesterone level is usually required to be > 15 ng/mL (some centers require > 20 ng/mL).

• Progesterone < 10 ng/mL: Indicates luteal phase deficiency; may need to increase progesterone dose or change administration route.
• Progesterone 10–15 ng/mL: Borderline range; needs comprehensive assessment based on clinical symptoms and β-hCG trend.
• Progesterone > 20 ng/mL: Usually indicates adequate luteal support.

Progesterone levels are affected by the time of testing and administration route (oral/injection/vaginal). Blood should be drawn at a fixed time, and results should be interpreted by a doctor.

4.3 Estradiol (E2)

Estradiol works synergistically with progesterone in early pregnancy to maintain endometrial stability and promote uterine blood flow. Patients with frozen embryo transfers in artificial cycles routinely receive exogenous estrogen supplementation. E2 is generally maintained within the range of 100–300 pg/mL. Too low E2 may lead to insufficient endometrial blood flow, while too high may be associated with OHSS risk.

5. Five Most Easily Overlooked Details

• Irregular medication timing: Luteal support medications must be taken strictly on time, especially progesterone injections and vaginal gels. Administer at a fixed time daily to maintain stable blood concentrations. Forgetting a dose or delaying it by more than 4 hours may cause progesterone fluctuations.
• Switching medications without consulting a doctor: When medications brought from Thailand run out or are unavailable, patients may switch to similar drugs bought domestically. Bioavailability may differ between manufacturers, leading to changes in blood levels. Always consult a reproductive doctor before switching.
• Proper technique for vaginal medications: After vaginal administration of Crinone or Utrogestan, the melted gel may form a white or yellowish discharge, which is normal. Some patients mistakenly think it's an infection or that the drug has leaked out and repeat the dose, leading to overdosage.
• Ignoring drug storage conditions: Crinone should be stored below 25°C, protected from light. Progesterone injections should be stored at room temperature, protected from light. High temperatures or freezing may affect drug stability.
• Stopping medication early or self-tapering: Some patients stop luteal support on their own after seeing a fetal heartbeat on ultrasound. This is a common cause of early miscarriage. Placental function is fully established only after 10–12 weeks of gestation; before that, the fetus relies on exogenous hormone supply.

6. Four Most Common Misconceptions to Avoid

7. Management of Special Situations

7.1 Vaginal Bleeding

The incidence of bleeding in early pregnancy is about 20–30%, and it does not always mean miscarriage. Management steps are as follows:

1. Assess the amount and color of bleeding: A small amount of brown or light pink discharge can be temporarily observed; reduce activity and avoid stress. Bright red blood, bleeding heavier than a menstrual period, or blood clots require immediate medical attention.
2. Emergency examination: Gynecological ultrasound to rule out ectopic pregnancy, cervical polyps, subchorionic hematoma, etc.; blood tests for β-hCG, progesterone, and complete blood count.
3. Medication adjustment: Under a doctor's guidance, increasing the progesterone dose or adding hemostatic medication may be necessary. Do not self-medicate.

7.2 Low Progesterone (< 10 ng/mL)

First, rule out the influence of blood draw time and testing method. After confirming low levels, the doctor will typically:

• Increase the dose of the current progesterone medication (e.g., progesterone injection from 40mg to 60mg/day).
• Combine different administration routes (e.g., triple therapy: oral + vaginal + injection).
• Recheck progesterone and β-hCG in 2–3 days to evaluate the effect of the adjustment.

If progesterone remains persistently low and β-hCG rises slowly or declines, be alert for possible embryonic developmental abnormalities or ectopic pregnancy.

7.3 Abdominal Pain

Mild lower abdominal discomfort or a dragging sensation is common in early pregnancy, related to uterine enlargement and ligament stretching. However, the following situations require vigilance:

• Severe unilateral lower abdominal pain: Needs to rule out ectopic pregnancy or ovarian cyst torsion.
• Abdominal pain with rectal pressure sensation: A classic sign of ruptured ectopic pregnancy.
• Abdominal pain with nausea, vomiting, bloating: Needs to rule out OHSS (especially in patients who recently conceived after egg retrieval).

7.4 Insufficient Medication from Thailand or Unable to Refill

This is a common practical issue in cross-border medical care. Recommendations:

• Before returning home, ask the Thai doctor for a detailed medication plan (in English or Chinese), including drug names, dosages, duration, and tapering schedule.
• Contact a local fertility center or tertiary hospital gynecology department in advance to confirm if drugs with the same ingredients and specifications are available.
• If identical drugs are not available domestically, ask a doctor to switch to a locally available equivalent based on equivalent dosage; do not convert the dose yourself.

8. Doctor's Perspective: Four Principles of Scientific Pregnancy Maintenance

As a reproductive doctor, I encounter patients returning after successful overseas IVF daily. Regarding pregnancy maintenance, I always emphasize the following four principles:

1. Individualized Plan: There is no "one-size-fits-all" plan. Patients over 38, with low ovarian reserve, recurrent implantation failure, or recurrent miscarriage history require more intensive luteal support and monitoring. The medication plan also differs between fresh embryo transfers and frozen embryo transfers (artificial/natural cycle).
2. Evidence-Based Medication, Avoid Overtreatment: More luteal support is not necessarily better. Excessive progesterone may suppress endogenous LH secretion, which is detrimental to placental function establishment. Dosage and target blood levels should refer to international guidelines (e.g., ASRM, ESHRE) combined with the patient's individual response.
3. Focus on the Whole Picture, Not Just Blood Values: The ultimate success of pregnancy maintenance is determined by ultrasound and pregnancy outcome. Don't be overly anxious about a single blood value fluctuation, and don't neglect necessary ultrasound checks just because blood values are normal.
4. Ensure Continuity of Cross-Border Medical Care: Patients choosing IVF in Thailand must obtain complete medical records (including medication plan, monitoring records, embryo information) before returning home. Establish a local obstetric or reproductive follow-up file as soon as possible after returning, and don't wait until medication runs out or abnormalities appear to see a doctor.